The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders. METHOD: For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs. RESULTS: In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific. CONCLUSION: Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which is significant contributor to the global burden of disease [7, 43].”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anxiety disorders cause 10.4% of the Disability Adjusted Life Years (DALYs) lost due to neurological, mental, substance use disorders and account for 1.1% of the global burden of disease worldwide, that is a total of 26,800,000 DALYs worldwide (Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015).”
From Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries (2018) · cites this paper as Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As described above, postpartum psychosis is a key marker for the risk of future affective disorder”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“In 2010, mental, neurological and substance abuse disorders accounted for 10.4% of all disability-adjusted life-years globally.21”
From Climate change, climate-related disasters and mental disorder in low- and middle-income countries: a scoping review (2021) · cites this paper as [21]
In the citing paper
“Recent prevalence estimates indicate 10.7% of the world’s population live with a mental health disorder, and the number of years lived with a mental health disorder has increased by 13.5% from 2007 to 2017”
From Explaining adults’ mental health help-seeking through the lens of the theory of planned behavior: A scoping review (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · cited 7×
“Overall, GBD 2010 findings highlighted a shift in burden from communicable to noncommunicable diseases and from YLLs to YLDs [1,11].”
InfluentialSelf-citationVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationWorld Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,970
(1996) · Cited by 6,884
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Self-citationDiagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )
Segal, D. L. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,666
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Self-citation
Cited by
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247
Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2018) · Science · doi:10.1126/science.aad6469 · Cited by 1,095
Andrews, G., Basu, A., Cuijpers, P., Craske, M. G., McEvoy, P., English, C. L., & Newby, J. M. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.01.001 · Cited by 922
Psychological Treatments for the World: Lessons from Low- and Middle-Income Countries
Singla, D. R., Kohrt, B. A., Murray, L. K., Anand, A., Chorpita, B. F., & Patel, V. (2017) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045217 · Cited by 913
Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00390-6 · Cited by 889
Self-citationEvans-Lacko, S., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Benjet, C., Bruffaerts, R., Chiu, W. T., Florescu, S., de Girolamo, G., Gureje, O., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291717003336 · Cited by 781
“Although mental disorders are a leading cause of disability (World Health Organization, 2012; Whiteford et al. 2015; Vigo et al. 2016), only a minority of people with these disorders receives treatment (Wang et al.”
BackgroundAlonso, J., Liu, Z., Evans-Lacko, S., Sadikova, E., Sampson, N., Chatterji, S., Abdulmalik, J., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H., et al. (2018) · Depression and Anxiety · doi:10.1002/da.22711 · Cited by 716
Stubbs, B., Vancampfort, D., Hallgren, M., Firth, J., Veronese, N., Solmi, M., Brand, S., Cordes, J., Malchow, B., Gerber, M., et al. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.07.004 · Cited by 697
Solmi, M., Seitidis, G., Mavridis, D., Correll, C. U., Dragioti, E., Guimond, S., Tuominen, L., Dargél, A., Carvalho, A. F., Fornaro, M., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02138-4 · Cited by 570
“For instance, in GBD 2010, females accounted for more DALYs in all mental disorders, except for mental disorders occurring in childhood, schizophrenia, and substance use disorders [16].”
Peters, S. K., Dunlop, K., & Downar, J. (2016) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2016.00104 · Cited by 611
“Overall, mental and substance use disorders (SUDs) accounted for 22.9% of the global burden of years of life lost to disability (Whiteford et al., 2013), with a prevalence of around one billion cases worldwide (Whiteford et al., 2015).”
BackgroundInfluentialAn overview of the features of chatbots in mental health: A scoping review
Abd-alrazaq, A. A., Alajlani, M., Alalwan, A. A., Bewick, B. M., Gardner, P., & Househ, M. (2019) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2019.103978 · Cited by 605
Abd-Alrazaq, A. A., Rababeh, A., Alajlani, M., Bewick, B. M., & Househ, M. (2020) · Journal of Medical Internet Research · doi:10.2196/16021 · Cited by 503
“Mental disorders impair quality of life and are considered one of the most common causes of disability [3].”
The case for systems thinking about climate change and mental health
Berry, H. L., Waite, T. D., Dear, K. B. G., Capon, A. G., & Murray, V. (2018) · Nature Climate Change · doi:10.1038/s41558-018-0102-4 · Cited by 485
Nutritional psychiatry: The present state of the evidence
Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469
Patel, V., Weobong, B., Weiss, H. A., Anand, A., Bhat, B., Katti, B., Dimidjian, S., Araya, R., Hollon, S. D., King, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31589-6 · Cited by 448
Therapeutic Uses of Triphala in Ayurvedic Medicine
Peterson, C. T., Denniston, K., & Chopra, D. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0083 · Cited by 368
NADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
Social brain, social dysfunction and social withdrawal
Porcelli, S., Van Der Wee, N., van der Werff, S., Aghajani, M., Glennon, J. C., van Heukelum, S., Mogavero, F., Lobo, A., Olivera, F. J., Lobo, E., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.012 · Cited by 391
Targeting the transferrin receptor for brain drug delivery
Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 370
Determinants of anxiety in elite athletes: a systematic review and meta-analysis
Rice, S. M., Gwyther, K., Santesteban-Echarri, O., Baron, D., Gorczynski, P., Gouttebarge, V., Reardon, C. L., Hitchcock, M. E., Hainline, B., & Purcell, R. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2019-100620 · Cited by 310
Castelpietra, G., Knudsen, A. K. S., Agardh, E. E., Armocida, B., Beghi, M., Iburg, K. M., Logroscino, G., Ma, R., Starace, F., Steel, N., et al. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100341 · Cited by 347
Self-citationPăsărelu, C. R., Andersson, G., Bergman Nordgren, L., & Dobrean, A. (2017) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2016.1231219 · Cited by 335
Mental health in the Americas: an overview of the treatment gap
Kohn, R., Ali, A. A., Puac-Polanco, V., Figueroa, C., López-Soto, V., Morgan, K., Saldivia, S., & Vicente, B. (2018) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2018.165 · Cited by 295
Air Pollution, Stress, and Allostatic Load: Linking Systemic and Central Nervous System Impacts
Thomson, E. M. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190015 · Cited by 290
“The societal implications are significant: neurological and mental health disorders globally represent the largest contributor to years lived with disability, and with an aging population the proportion of affected individuals is growing [3, 4].”
BackgroundPerceptions and opinions of patients about mental health chatbots: scoping review
Abd-Alrazaq, A. A., Alajlani, M., Ali, N., Denecke, K., Bewick, B. M., & Househ, M. (2021) · Journal of Medical Internet Research · doi:10.2196/17828 · Cited by 301
“Mental disorders have a negative effect on the quality of life and are one of the most common causes of disability [2].”
Inflammatory Biomarkers and Risk of Schizophrenia: A 2-Sample Mendelian Randomization Study
Hartwig, F. P., Borges, M. C., Horta, B. L., Bowden, J., & Davey Smith, G. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3191 · Cited by 302
Moore, T. H. M., Kesten, J. M., López-López, J. A., Ijaz, S., McAleenan, A., Richards, A., Gray, S., Savović, J., & Audrey, S. (2018) · Health & Place · doi:10.1016/j.healthplace.2018.07.012 · Cited by 269
Sexual dimorphism in predisposition to Alzheimer's disease
Fisher, D. W., Bennett, D. A., & Dong, H. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.004 · Cited by 270
“In addition, women consistently have a higher age-specific prevalence of disability globally (Buttery et al., 2016; Crimmins et al., 2011; Freedman et al., 2016; Jagger et al., 2016; Wahrendorf et al., 2013; Whiteford et al., 2015).”
The microbiome, immunity, and schizophrenia and bipolar disorder.
Dickerson, F., Severance, E., & Yolken, R. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.12.010 · Cited by 268
“Prevalence estimates for any psychiatric comorbidity in patients diagnosed with irritable bowel syndrome (IBS), for example, range from 54 to 94% (Whitehead et al., 2002), and specifically estimates for a schizophrenia comorbidity approach 20% (Gupta et al., 1997).”
BackgroundA Mental Health Chatbot for Regulating Emotions (SERMO) - Concept and Usability Test
Denecke, K., Vaaheesan, S., & Arulnathan, A. (2021) · IEEE Transactions on Emerging Topics in Computing · doi:10.1109/tetc.2020.2974478 · Cited by 237
Walking on sunshine: Scoping review of the evidence for walking and mental health
Kelly, P., Williamson, C., Niven, A. G., Hunter, R., Mutrie, N., & Richards, J. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098827 · Cited by 253
Moitra, M., Santomauro, D., Degenhardt, L., Collins, P. Y., Whiteford, H., Vos, T., & Ferrari, A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.053 · Cited by 252
Self-citationThe Emerging Neurobiology of Bipolar Disorder
Harrison, P. J., Geddes, J. R., & Tunbridge, E. M. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.006 · Cited by 229
The burden of psychosocial morbidity related to cancer: patient and family issues
Caruso, R., Nanni, M. G., Riba, M. B., Sabato, S., & Grassi, L. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1288090 · Cited by 244
“…and especially when comorbid with physical illnesses, are accompanied by a high burden, accounting for a high percentages of global DALYs (Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015) that has increased the need for priority actions on the global health agenda (Whiteford & Ferrari, 2016).”
BackgroundThe global prevalence of postpartum psychosis: a systematic review
on behalf of the Maternal Morbidity Working Group, VanderKruik, R., Barreix, M., Chou, D., Allen, T., Say, L., & Cohen, L. S. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1427-7 · Cited by 238
“As described above, postpartum psychosis is a key marker for the risk of future affective disorder, which is significant contributor to the global burden of disease [7, 43].”
BackgroundLynch, S. J., Sunderland, M., Newton, N. C., & Chapman, C. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102036 · Cited by 194
Xu, Y., Hackett, M., Carter, G., Loo, C., Gálvez, V., Glozier, N., Glue, P., Lapidus, K., McGirr, A., Somogyi, A. A., et al. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv124 · Cited by 226
“Recent trials have also suggested possible benefits among patients with posttraumatic stress disorder (Whiteford et al., 2015) and in obsessive compulsive disorder (Rodriguez et al.”
BackgroundCastaldelli-Maia, J. M., & Bhugra, D. (2022) · International Review of Psychiatry · doi:10.1080/09540261.2022.2040450 · Cited by 187
Virtanen, M., Jokela, M., Madsen, I. E., Magnusson Hanson, L. L., Lallukka, T., Nyberg, S. T., Alfredsson, L., Batty, G. D., Bjorner, J. B., Borritz, M., et al. (2018) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.3712 · Cited by 268
“Given that the burden of mental disorders peaks at working age (1), workingage populatio ns are an important target for prevention.”
BackgroundInfluentialRemission from substance use disorders: A systematic review and meta-analysis
Fleury, M.-J., Djouini, A., Huỳnh, C., Tremblay, J., Ferland, F., Ménard, J.-M., & Belleville, G. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.08.625 · Cited by 205
Bipolar depression: the clinical characteristics and unmet needs of a complex disorder
McIntyre, R. S., & Calabrese, J. R. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1636017 · Cited by 211
Hoppen, T. H., & Morina, N. (2019) · European Journal of Psychotraumatology · doi:10.1080/20008198.2019.1578637 · Cited by 180
Hickie, I. B., Scott, E. M., Cross, S. P., Iorfino, F., Davenport, T. A., Guastella, A. J., Naismith, S. L., Carpenter, J. S., Rohleder, C., Crouse, J. J., et al. (2019) · Medical Journal of Australia · doi:10.5694/mja2.50383 · Cited by 208
Esmaeelzadeh, S., Moraros, J., Thorpe, L., & Bird, Y. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120543 · Cited by 182
Ostacher, M., Ng-Mak, D., Patel, P., Ntais, D., Schlueter, M., & Loebel, A. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1285050 · Cited by 202
“In 2010, the World Health Organisation estimated that bipolar disorder affected 58.9 million people globally (Whiteford et al. 2015), with the lifetime prevalence rate estimated at 2.4% (Merikangas et al. 2011).”
BackgroundInfluentialA Review of Mental Health and Mental Health Care Disparities Research: 2011-2014
Cook, B. L., Hou, S. S.-Y., Lee-Tauler, S. Y., Progovac, A. M., Samson, F., & Sanchez, M. J. (2019) · Medical Care Research and Review · doi:10.1177/1077558718780592 · Cited by 178
Charlson, F. J., Baxter, A. J., Dua, T., Degenhardt, L., Whiteford, H. A., & Vos, T. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000687 · Cited by 185
Self-citationOlloquequi, J., Cornejo-Córdova, E., Verdaguer, E., Soriano, F. X., Binvignat, O., Auladell, C., & Camins, A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754680 · Cited by 189
Youth mental health in the time of COVID-19
Power, E., Hughes, S., Cotter, D., & Cannon, M. (2020) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2020.84 · Cited by 192
“Mental disorders are the largest cause of years lived with disability worldwide (Whiteford et al. 2015).”
BackgroundOmega-3 fatty acids and mental health
Lange, K. W. (2020) · Global Health Journal · doi:10.1016/j.glohj.2020.01.004 · Cited by 171
Bollyky, T. J., Templin, T., Cohen, M., Schoder, D., Dieleman, J. L., & Wigley, S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30235-1 · Cited by 189
Mughal, A. Y., Devadas, J., Ardman, E., Levis, B., Go, V. F., & Gaynes, B. N. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02753-3 · Cited by 172
Hollis, C., Sampson, S., Simons, L., Davies, E. B., Churchill, R., Betton, V., Butler, D., Chapman, K., Easton, K., Gronlund, T. A., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30296-7 · Cited by 186
SPWVD-CNN for Automated Detection of Schizophrenia Patients Using EEG Signals
Khare, S. K., Bajaj, V., & Acharya, U. R. (2021) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2021.3070608 · Cited by 182
Maletic, V., Eramo, A., Gwin, K., Offord, S. J., & Duffy, R. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00042 · Cited by 166
The genetic epidemiology of substance use disorder: A review
Prom-Wormley, E. C., Ebejer, J., Dick, D. M., & Bowers, M. S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.040 · Cited by 175
Artificial Intelligence for Chatbots in Mental Health: Opportunities and Challenges
Denecke, K., Abd-Alrazaq, A., & Househ, M. (2021) · Lecture Notes in Bioengineering · doi:10.1007/978-3-030-67303-1_10 · Cited by 177
Feng, Z., Li, Q., Zhou, L., Chen, Z., & Yin, W. (2021) · Public Health · doi:10.1016/j.puhe.2021.06.023 · Cited by 170
Association of Urbanicity With Psychosis in Low- and Middle-Income Countries
DeVylder, J. E., Kelleher, I., Lalane, M., Oh, H., Link, B. G., & Koyanagi, A. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0577 · Cited by 171
Manyema, M., Norris, S. A., & Richter, L. (2018) · BMC Public Health · doi:10.1186/s12889-018-5767-0 · Cited by 186
“Mental, neurological and substance use disorders constitute a significant global disease burden, with 10% of global disability-adjusted life years (DALYs) attributed to these disorders in 2010 [12, 13].”
BackgroundBatra, S., Baker, R., Wang, T., Forma, F., DiBiasi, F., & Peters-Strickland, T. (2017) · Medical Devices: Evidence and Research · doi:10.2147/mder.s144158 · Cited by 169
Addressing the burden of epilepsy: Many unmet needs
Beghi, E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.003 · Cited by 178
Ullah, Z., Alasmari, A., Tariq, M., & Fatani, A. J. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s93937 · Cited by 182
“Introduction Neuropsychiatric diseases are one of the leading causes of global disease burden, which significantly contribute to disability and adjusted life years.(1) Treatment of central nervous system (CNS) diseases is particularly challenging because of a variety of formidable obstacles that often impede drug deli…”
Connery, H. S., McHugh, R. K., Reilly, M. E., Shin, S., & Greenfield, S. F. (2020) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000271 · Cited by 177
New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis
Liu, Y.-W., Liong, M., & Tsai, Y.-C. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-8079-2 · Cited by 172
A Scoping Review of the Relationship between Running and Mental Health
Oswald, F., Campbell, J., Williamson, C., Richards, J. A., & Kelly, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17218059 · Cited by 177
Ye, J., Wen, Y. F., Sun, X., Chu, X., Li, P., Cheng, B., Cheng, S., Liu, L., Zhang, L., Ma, M., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.11.019 · Cited by 157
Jesus, T. S., Landry, M. D., & Hoenig, H. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16060980 · Cited by 164
Religious education can contribute to adolescent mental health in school settings
Estrada, C. A. M., Lomboy, M. F. T. C., Gregorio, E. R., Amalia, E., Leynes, C. R., Quizon, R. R., & Kobayashi, J. (2019) · International Journal of Mental Health Systems · doi:10.1186/s13033-019-0286-7 · Cited by 173
“5% of global years lived with disability (YLDs) [1].”
Beattie, T. S., Smilenova, B., Krishnaratne, S., & Mazzuca, A. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003297 · Cited by 151
Young, L. M., Pipingas, A., White, D. J., Gauci, S., & Scholey, A. (2019) · Nutrients · doi:10.3390/nu11092232 · Cited by 148
“Conditions such as depression, dysthymia, and anxiety place a large burden on the health care system since they account for a significant proportion of the world’s disease burden [1].”
BackgroundUnemployment and Substance Use: An Updated Review of Studies from North America and Europe
Nolte-Troha, C., Roser, P., Henkel, D., Scherbaum, N., Koller, G., & Franke, A. G. (2023) · Healthcare · doi:10.3390/healthcare11081182 · Cited by 168
The Relationship Between Satisfaction With Life and Depression Symptoms by Gender
Gigantesco, A., Fagnani, C., Toccaceli, V., Stazi, M. A., Lucidi, F., Violani, C., & Picardi, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00419 · Cited by 140
“9% of years lived with disability (YLDs) in 2010 (2).”
BackgroundStubbs, B., Vancampfort, D., Firth, J., Schuch, F. B., Hallgren, M., Smith, L., Gardner, B., Kahl, K. G., Veronese, N., Solmi, M., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.104 · Cited by 138
“Depression is a leading cause of global years lived with disability (Whiteford et al., 2015).”
BackgroundMental health impact of social capital interventions: A systematic review
Flores, E. C., Fuhr, D. C., Bayer, A. M., Lescano, A. G., Thorogood, N., & Simms, V. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-017-1469-7 · Cited by 135
Duration of untreated illness as a key to early intervention in schizophrenia: a review.
Murru, A., & Carpiniello, B. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.003 · Cited by 135
“In particular, the total costs for SCZ seem to be mainly determined by indirect costs such as sick days, unemployment, incomplete education, long-term disability, and suicide attempts [3], [4].”
BackgroundWeobong, B., Weiss, H. A., McDaid, D., Singla, D. R., Hollon, S. D., Nadkarni, A., Park, A.-L., Bhat, B., Katti, B., Anand, A., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002385 · Cited by 135
“Despite the well-documented health and economic consequences of depression [2,3], investments in mental health are inadequate, resulting in a large treatment gap [3].”
BackgroundSeasonality and symptoms of depression: A systematic review of the literature
Øverland, S. N., Woicik, W., Sikora, L., Whittaker, K. J., Heli, H. A., Skjelkvåle, F. S., Sivertsen, B., & Colman, I. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000209 · Cited by 152
Pihlaja, S., Stenberg, J.-H., Joutsenniemi, K., Mehik, H., Ritola, V., & Joffe, G. (2018) · Internet Interventions · doi:10.1016/j.invent.2017.11.005 · Cited by 134
“Depression and anxiety disorders, the most prevalent mental health problems (Whiteford et al., 2015) show great comorbidity (Kaufman and Charney, 2000), phenomenological and genetic overlap (Hattema, 2008), similarities in pharmacological treatment (Levine et al., 2001) and appear to share the same…”
BackgroundPrevalence of depression among type 2 diabetes mellitus patients in India: A meta-analysis
Hussain, S., Habib, A., Singh, A., Akhtar, M., & Najmi, A. K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.037 · Cited by 138
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
Hoch, E., Niemann, D., von Keller, R., Schneider, M., Friemel, C. M., Preuss, U. W., Hasan, A., & Pogarell, O. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00984-4 · Cited by 131
“Keywords Mental disorders · Cannabis · Cannabinoids · THC · CBD · Medical cannabis · Treatment Introduction Mental disorders are among the leading causes of health impairments [25, 77, 89, 91] involving significant changes in thinking, perception, emotion, behavior and relationships [4].”
BackgroundAkkol, E. K., Çankaya, İ. İ. T., Karatoprak, G. Ş., Çarpar, E., Sobarzo‐Sánchez, E., & Capasso, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.669638 · Cited by 138
“In so far as lifetime occurrence is to be considered, neurological diseases represent a significant load of chronic disability and financial burden globally especially in the older age group (Whiteford et al., 2015).”
BackgroundPrevalence of anxiety, depression and post-traumatic stress disorder in the Kashmir Valley
Housen, T., Lenglet, A., Ariti, C. A., Shah, S., Shah, H., Ara, S., Viney, K. A., Janes, S., & Pintaldi, G. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2017-000419 · Cited by 132
“IntroductIon Globally, psychological disorders make up a large proportion of disease burden and are recognised as the leading cause of years of life lived with a disability (Disability-Adjusted Life Years).(1) 2 This results in decreased productivity and has a negative impact on the quality of life of affected individ…”
BackgroundShabbir, U., Rubab, M., Tyagi, A., & Oh, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010196 · Cited by 127
“Globally, mental disorders are one of the main reasons for disability and pointing concerns for public health issues [1].”
BackgroundThe genetics of depression: successful genome-wide association studies introduce new challenges
Ormel, J., Hartman, C. A., & Snieder, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0450-5 · Cited by 130
A Meta-analysis of Retinal Cytoarchitectural Abnormalities in Schizophrenia and Bipolar Disorder
Lizano, P. L., Bannai, D., Lutz, O., Kim, L. A., Miller, J. B., & Keshavan, M. S. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz029 · Cited by 121
Sharpe, I., & Davison, C. M. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051908 · Cited by 118
Folker, A. P., Mathiasen, K., Lauridsen, S. M., Stenderup, E., Dozeman, E., & Folker, M. P. (2018) · Internet Interventions · doi:10.1016/j.invent.2018.02.001 · Cited by 116
Substance Abuse and Public Health: A Multilevel Perspective and Multiple Responses
Lo, T. W., Yeung, J. W. K., & Tam, H.-L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072610 · Cited by 116
“Nevertheless, professionals and researchers of different domains tend to adopt a one-dimensional view based on their particular expertise when examining, explaining and trying to find solutions to this complex problem [10,48,49].”
BackgroundAdams, C., Gringart, E., & Strobel, N. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02034-y · Cited by 115
Stevenson, A., Akena, D. H., Stroud, R. E., Atwoli, L., Campbell, M., Chibnik, L. B., Kwobah, E., Kariuki, S. M., Martin, A. R., de Menil, V. P., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025469 · Cited by 117
Nichter, B., Norman, S. B., Haller, M. M., & Pietrzak, R. H. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.109744 · Cited by 116
Shared decision-making interventions for people with mental health conditions
Aoki, Y., Yaju, Y., Utsumi, T., Sanyaolu, L. N., Storm, M., Takaesu, Y., Watanabe, K., Watanabe, N., Duncan, E., & Edwards, A. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007297.pub3 · Cited by 129
Lofts, A., Abu-Hijleh, F. A., Rigg, N., Mishra, R. K., & Hoare, T. R. (2022) · CNS Drugs · doi:10.1007/s40263-022-00930-4 · Cited by 132
Barros, P., Fat, L. N., Garcia, L., Slovic, A., Thomopoulos, N., de Sá, T. H., Morais, P., & Mindell, J. (2019) · Cities · doi:10.1016/j.cities.2019.05.015 · Cited by 98
Petersen, I., van Rensburg, A., Kigozi, F., Semrau, M., Hanlon, C., Abdulmalik, J., Kola, L., Fekadu, A., Gureje, O., Gurung, D., et al. (2019) · BJPsych Open · doi:10.1192/bjo.2019.7 · Cited by 111
Indicators of mental disorders in UK Biobank—A comparison of approaches
Davis, K. A. S., Cullen, B., Adams, M., Brailean, A., Breen, G., Coleman, J. R. I., Dregan, A., Gaspar, H. A., Hübel, C., Lee, W., et al. (2019) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1796 · Cited by 111
“The presence of self-reported diagnosis was associated with a greater risk of all symptom-based outcomes, not just for equivalent outcomes, which reflects the co-morbidities between disorders often unrecognised (Oiesvold et al., 2013; Whiteford et al., 2015).”
BackgroundZwerenz, R., Becker, J., Knickenberg, R. J., Siepmann, M., Hagen, K., & Beutel, M. E. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000481177 · Cited by 108
Nyongesa, M. K., Mwangi, P. M., Koot, H. M., Cuijpers, P. J., Newton, C. R. J. C., & Abubakar, A. A. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00312-4 · Cited by 109
Implementation of Cognitive Behavioral Therapy in e–Mental Health Apps: Literature Review
Denecke, K., Schmid, N., & Nüssli, S. (2022) · Journal of Medical Internet Research · doi:10.2196/27791 · Cited by 107
“Apart from the fact that mental disorders have an impact on people’s quality of life, they are one of the most common causes of occupational disability [2], resulting in high economic costs.”
Background
Metadata
- Authors
- Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T.
- Affiliations
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Auckland University of Technology (NZ)
- University of Washington (US)
- Corresponding author
- Whiteford, Harvey A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-06
- Volume
- 10
- Issue
- 2
- Pages
- e0116820
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4320057
- OpenAlex
- W2006103193
- Semantic Scholar
- 29fdb08fe359a077ba5ecfea8813becf7defce8c
- Cited by
- 1,175
- References
- 47
- Citations by year
- 2026: 34 · 2025: 63 · 2024: 83 · 2023: 111 · 2022: 121 · 2021: 142 · 2020: 145 · 2019: 143 · 2018: 123 · 2017: 113 · 2016: 66 · 2015: 29
- FWCI
- 180.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bill and Melinda Gates Foundation
- Australian Government
- University of New South Wales
- Medical Research Council
- National Health and Medical Research Council (1041742)
- National Drug and Alcohol Research Centre
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- mental illness, neurological disorders, substance use disorders, global burden of disease, disability-adjusted life years, years lived with disability, prevalence trends, sex differences, age differences, regional variation, schizophrenia, Parkinson's disease, epilepsy
- MeSH terms
- Age Factors, Bayes Theorem, Mental Disorders, Female, Geography, Humans, Male, Nervous System Diseases, Regression Analysis, Time Factors, Global Health, Prevalence, Cost of Illness, Quality-Adjusted Life Years, Substance-Related Disorders, Mortality, Premature
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.